Quinapril. A review of its pharmacological properties, and therapeutic efficacy in cardiovascular disorders (Q36657490)

15 August 2017

1 reference

title

Quinapril. A review of its pharmacological properties, and therapeutic efficacy in cardiovascular disorders (English)

1 reference

15 August 2017

2

Brogden RN

1 reference

15 August 2017

Wadworth AN

1

1 reference

15 August 2017

1 March 1991

1 reference

15 August 2017

1 reference

15 August 2017

41

1 reference

15 August 2017

3

1 reference

15 August 2017

378-399

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199141030-00006

15 August 2017

0 references

cites work

The management of hypertension in older patients

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairment

1 reference

12 December 2020

The clinical pharmacokinetics of quinapril

1 reference

12 December 2020

Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat

1 reference

12 December 2020

The renin-angiotensin system in the control of systemic arterial pressure

1 reference

12 December 2020

Quinapril and blood lipids

1 reference

12 December 2020

The Treatment of Moderate to Severe Hypertension with ACE Inhibitors

1 reference

12 December 2020

Rational design and biochemical utility of specific inhibitors of angiotensin-converting enzyme

1 reference

12 December 2020

The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure

1 reference

12 December 2020

Influence of food on the pharmacokinetics of quinapril and its active diacid metabolite, CI-928

1 reference

12 December 2020

Quinapril--a preclinical review of the pharmacology, pharmacokinetics, and toxicology

1 reference

12 December 2020

Digoxin, Converting-Enzyme Inhibition (Quinapril), and the Combination in Patients with Congestive Heart Failure Functional Class II and Sinus Rhythm

1 reference

12 December 2020

CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

Enalapril. An update of its pharmacological properties and therapeutic use in congestive heart failure

1 reference

12 December 2020

Enzyme inhibitors of the renin-angiotensin system.

1 reference

12 December 2020

Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders

1 reference

12 December 2020

Effects of single doses of quinapril and atenolol on autonomic nervous function and exercise capacity in healthy volunteers

1 reference

12 December 2020

New directions in antihypertensive drug therapy

1 reference

12 December 2020

Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy

1 reference

12 December 2020

Inhibition of angiotensin-converting enzyme with quinapril (CI-906): investigation of antihypertensive mechanisms in spontaneously hypertensive rats.

1 reference

12 December 2020

Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system

1 reference

12 December 2020

Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure

1 reference

12 December 2020

The acute haemodynamic effects of quinapril, a new non-sulfhydryl angiotensin converting enzyme inhibitor, in patients with severe congestive cardiac failure.

1 reference

12 December 2020

Determination of quinapril and its active metabolite in human plasma and urine by gas chromatography with electron-capture detection

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors in the treatment of mild to moderate essential hypertension

1 reference

12 December 2020

Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin system, and prostanoids in essential hypertension

1 reference

12 December 2020

Angiotensin converting enzyme in the rat heart: studies of its inhibition in vitro and ex vivo

1 reference

12 December 2020

The hemodynamics effects of ACE inhibitors in the treatment of congestive heart failure

1 reference

12 December 2020

Effects of two structurally different angiotensin-converting enzyme inhibitors, captopril and quinapril (CI-906), in rats with one-kidney deoxycorticosterone-salt hypertension

1 reference

12 December 2020

Hemodynamic effects of quinapril, a novel angiotensin-converting enzyme inhibitor.

1 reference

12 December 2020

Multiple-dose propranolol administration does not influence the single dose pharmacokinetics of quinapril and its active metabolite (quinaprilat)

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors. Emerging differences and new compounds

1 reference

12 December 2020

The safety and tolerability of quinapril

1 reference

12 December 2020

[Angiotensin-converting enzyme inhibitors in angina pectoris]

1 reference

12 December 2020

Angiotensin converting enzyme inhibitors: differences and advantages for first line therapy in hypertension

1 reference

12 December 2020

Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

12 December 2020

The treatment of mild to moderate hypertension with ACE inhibitors

1 reference

12 December 2020

Multiple-dose cimetidine administration does not influence the single-dose pharmacokinetics of quinapril and its active metabolite (CI-928)

1 reference

12 December 2020

Present aspects and future developments with ACE inhibitors

1 reference

12 December 2020

Quinapril reduces arterial blood pressure and improves metabolic control in elderly hypertensive diabetic patients

1 reference

12 December 2020

Preliminary hemodynamic report of the efficacy and safety of quinapril in acute and chronic treatment of patients with congestive heart failure.

1 reference

12 December 2020

Antihypertensive profile of the angiotensin-converting enzyme inhibitors CI-906 and CI-907

1 reference

12 December 2020

Synthesis of novel angiotensin converting enzyme inhibitor quinapril and related compounds. A divergence of structure-activity relationships for non-sulfhydryl and sulfhydryl types

1 reference

12 December 2020

Differing effects of two angiotensin converting enzyme inhibitors, captopril and CI-906, on diuresis and the urinary excretion of kallikrein and prostaglandins in spontaneously hypertensive rats

1 reference

12 December 2020

Overview of quinapril, a new ACE inhibitor

1 reference

12 December 2020

Pilot Study of the Effects of the Angiotensin-Converting Enzyme Inhibitor CI-906 on Patients with Essential Hypertension

1 reference

12 December 2020

Quinapril: a double-blind, placebo-controlled trial in essential hypertension

1 reference

12 December 2020

Inhibition of angiotensin-converting enzyme (ACE) in plasma and tissue.

1 reference

12 December 2020

Comparison of the efficacy and safety of quinapril vs. captopril in treatment of moderate to severe hypertension

1 reference

12 December 2020

A comparison of the efficacy and safety of quinapril with that of enalapril in the treatment of mild to moderate essential hypertension

1 reference

12 December 2020

Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?

1 reference

12 December 2020

10.2165/00003495-199141030-00006

Identifiers

DOI

1 reference

PubMed ID

1711445

Dimensions Publication ID

15 August 2017

0 references

1 reference

PubMed ID

1711445